IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for Relapsed/Refractory Primary Central Nervous System Lymphoma
Drug: Rituximab
14 locations incl. Phoenix
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All·Age: 18+
Code: NCT07104032·Phase 3·Recruiting